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ABSTRACT
Objective: The objective of this selective EBM review is to determine whether or not “Is ginger
an effective treatment for reducing the severity of chemotherapy-induced nausea in breast cancer
patients?”
Study Design: The systematic review of three English language, peer reviewed, randomized
control trials have been published between 2015 and 2016.
Data Sources: Three randomized control trials were obtained using the PubMed database. One
single-blind randomized control trial, one double-blinded randomized control trial, and one
double-blind Phase II-III randomized control trial.
Outcomes Measured: The participants of the trials graded the severity of nausea after the
intervention of ginger or the control. Each study assessed patient-oriented outcomes. The
outcomes measured were analyzed via visual analog scale7,8, European Organization for
Research and Treatment of Cancer Quality of Life Questionnaire8, and self-reported severity of
nausea questionnaire6.
Results: All three studies did not show a significant improvement in the severity of nausea in
breast cancer patients receiving chemotherapy after the treatment of ginger. However, one study
showed a positive benefit in the health-related quality of life after using ginger essential oil
aromatherapy.
Conclusion: The three randomized control trials used in this systematic review did not show an
improvement in the severity of chemotherapy-induced nausea when using ginger as a treatment
intervention. There were too many limitations determined in the three control trials which could
have cause insignificant results. Although, participants in the single-blinded control trial reported
positive improvement in the health-related quality of life.
Keywords: Nausea, Chemotherapy, Ginger
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INTRODUCTION
Chemotherapy-induced nausea (CIN) is a common and stressful acute side effect to
pharmacologic treatment of cancer. Nausea is a feeling that is subjective and causes disturbance
to the digestive tract. Therefore, nausea is a distressing sensation that is typically felt in the
posterior pharynx or epigastrium. The onset of nausea has been found to be acute or delayed
depending upon the chemotherapy drug.1 Acute nausea is likely to occur within 24 hours of
administration of chemotherapy, while delayed nausea is defined to occur more than 24 hours
after administration of chemotherapy.1 This side effect of chemotherapy drugs provokes a major
impact on the lives of cancer patients. This systematic review evaluates the efficacy of ginger as
a nonpharmacological treatment to chemotherapy-induced nausea.
According to the National Cancer Institute, the prevalence of CIN occurs in 80% of
cancer patients.1 This common side effect needs to be managed and monitored medically. Cancer
patients are managed by a medical team, one which includes physician assistants (PAs). As of
2017, there were 1355 PAs with a career in oncology.2 Out of that number, 70.5% of those PAs
provided services for diagnosis, treatment, and management of cancer as a chronic illness.2
Chemotherapy can treat many cancers, however this systematic review analyzed studies
involving breast cancer patients. As of 2012, there were 3 million women living with breast
cancer in America which all require healthcare visits.3 Each healthcare visit has a cost and the
exact cost of treatment depends on the stage of cancer. The stages include 0, I, II, III, and IV
which can cost anywhere from $71,909 to $182,655 for treatment.3 Overall, the cost is higher for
patients with an advanced cancer at diagnosis.
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There has been significant progress at understanding the cause of CIN. The sensation of
nausea is controlled neurologically by the central nervous system, specifically autonomic
nerves.1 It is known that areas of the brain such as the cerebral cortex, limbic system, activation
of chemoreceptor trigger zones, and the vestibular-labyrinethine are all involved in producing a
nauseous sensation.1 It is known that the dose, route of administration, and schedule of
chemotherapy drugs all can contribute to CIN.4 In addition, patients younger than 50 years old,
women, a history of alcohol abuse, and history of motion sickness are more likely to experience
CIN.1 While cancer does not have a definite cure, patients will need to receive a chemotherapy
depending on the severity of the cancer and it is possible to experience nausea a side effect.
The treatment of CIN is classically managed with pharmacologic therapies known as
anti-emetics. This group of drugs work by blocking specific neurotransmitters that are otherwise
known to activate the chemoreceptor trigger zones. Some of the neurotransmitters include
serotonin, histamine, acetylcholine, and dopamine.1 Medications to treat CIN include
ondansetron, granisetron, metoclopramide, and dexamethasone.1 Many anti-emetic drugs are
used in combination depending upon how high the risk that nausea will be produced by the
chemotherapy drug. Anti-emetic medications can be administered via oral pills, parenteral
injection, transdermal patch, and rectal suppository.
This systematic review analyzes three randomized control trials that use ginger as a nonpharmalogical treatment for CIN to improve patients’ quality of life. Ginger is considered to be
used as a natural alternative to relieve CIN in patients that do not desire pharmalogical drugs or
patients who are resistant to those drugs. Ginger is a form of herbal therapy that has been used
for thousands of years in cultures such as ancient China and India.5 This earth-produced plant has
been used in studies to treat cancer, diabetes mellitus, inflammation, vomiting, and nausea.5
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OBJECTIVE
The objective of this EBM review it to determine whether or not “Is ginger an effective
treatment for reducing the severity of chemotherapy-induced nausea in breast cancer patients?”
METHODS
The studies used in this systematic review are all randomized control trials found on
PubMed. The population of all three studies included female patients diagnosed with breast
cancer who experienced nausea as a symptom caused by chemotherapy. The patient population
included in the studies were over 18 years old. The intervention used in all the studies was
ginger. Ansari et Al. and Thamlikitikul et Al. both used a 500-mg ginger capsule.6,7 However,
Lua et Al. used ginger aromatherapy.8 The comparison group in all studies used a visually
matched placebo as the control. The outcome measured was determined by the efficacy of ginger
by rating the severity of nausea and determining the health-related quality of life.
The key words used during the research of this systematic review included “ginger”,
“nausea”, “chemotherapy”, and “breast cancer”. The studies were all selected by pertinence of
the clinical question from the PubMed database. Each study has been published in peer reviewed
journals in the English language. The studies selected for this systematic review included
outcomes that were patient-oriented. The inclusion criteria incorporated the studies needed to be
randomized, controlled, blinded, published after 2010, and with patient oriented outcomes. The
participants needed to be diagnosed with breast cancer, receiving chemotherapy, and
experiencing nausea. The exclusion criteria included participants under the age of 18 and a
diagnosis other malignancies. The statistics reported include ANOVA, p-value, RBI, ABI, and
NNT. Table 1 consists of demographics and characteristics of the studies used in this review.
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Table 1: Demographics & Characteristics of the studies in this systematic review

Study

Type

# Pts

Ages
(yrs)

Inclusion Criteria

Exclusion Criteria

W/D

Interventions

Ansari6
(2016)

DoubleBlind,
Phase
II-III,
RCT

150

48.6
(25-79)

-Diagnosed
breast cancer
-Receiving AC,
CAF, TAC
chemotherapy
-At least 3
chemotherapy
cycles

31

500 mg ginger
powder BID
for 3 days

Lua8
(2015)

Singleblind
RCT

75

47.3
±9.26

15

Breathe deeply
into
aromatherapy
necklace at
least 3 times a
day for at least
3 periods of 2
minutes

Thamlikitkul7
(2017)

Doubleblind
RCT

34

>18
years
old

-Women >18
-Normal sense of
small
-Diagnosed with
breast cancer and
receiving
chemotherapy
-at least two
chemotherapy
courses
remaining
- >18 years old
-diagnosed with
breast cancer
-experienced
vomiting or
nausea
-received first
cycle of
chemotherapy
-at least two
cycles
chemotherapy

-History of previous
malignancy or
chemotherapy
-History of another
systematic disease,
metastatic
condition, or
receiving antiemetic
drugs
-Pts with other
malignancies
-Pts allergic to
ginger, perfumes, or
cosmetics
-Pts undergoing
radiation therapy

-Pregnant
-Lactating
-Nausea/ vomiting
prior to
chemotherapy
-Bleeding diathesis
-ginger allergy
-concomitant
treatment with other
chemotherapy
- other conditions
that cause nausea/
vomiting

1

500 mg ginger
capsule BID
for 5 days
starting the
first day of the
second
chemotherapy
cycle
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OUTCOMES MEASURED

The outcomes measured in the systematic review used three randomized control trials
that assessed patient oriented outcomes (POEMS). The control trials analyzed ginger as a
treatment to manage nausea as a result of chemotherapy drugs. Lua et Al. used a visual analog
scale (VAS) to measure the severity of nausea.8 Also, Lua et Al. measured participants health
related quality of life (HRQoL) while experiencing CIN by the European Organization for
Research and Treatment of Cancer Quality of Life Questionnaires (EORTC QLQ-C30).8 Ansari
et Al. used participant reported adverse events that occurred during the study period.6
Thamlikitikul et Al. used a questionnaire to record severity which included a VAS.7
RESULTS
This systematic review used three randomized control trials to determine if ginger could
improve the severity of nausea produced by chemotherapy and enhance quality of life in breast
cancer patients. Each trial evaluated the severity of nausea differently. There are two trials that
contain dichotomous data and one trial that has continuous data.
Ansari et Al. studied 150 patients that were recently diagnosed with breast cancer and
would receive chemotherapy in Iran. The participants were randomly separated by a radiation
oncology resident into two groups of ginger (n=75) and control (n=75).6 The patients along with
the attending oncologists were unaware of the content within the capsule. The inclusion and
exclusion criteria of Ansari et Al. study is shown in Table 1. Participants in the experimental and
control group were asked to consume two capsules every 12 hours for 3 days.6 The participants
were instructed to self-record severity of nausea during each chemotherapy cycle. Nausea was
graded by no nausea or nausea with three levels of severity.
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At the conclusion of the study, 31 patients were not accounted for in the results.6 This
group of patients did not properly record severity of nausea on most days. The participants forgot
to record their symptoms and were excluded from the study. However, 119 participants were
included in the experimental (n=57) and the control (n=62) with appropriate recordings of nausea
severity.6
The results of Ansari et Al. study concluded that the intervention was not statistically
significant. The author of this systematic review converted continuous data to dichotomous for
the third cycle of chemotherapy results. The study gave the number of subjects that in the control
arm and the ginger arm whom did not experience nausea. The control arm that scored 0 consisted
of 20 out of 62 subjects.6 While the ginger arm scored 0 was 23 out of 57 subjects.6 RBI, ABI,
and NNT are calculated in Table 2. For this treatment to show effectiveness, there would need to
be 13 patients treated for 1 more patient to experience relief of nausea with a ginger intervention
which is a small treatment effect. The study provided the mean nausea severity scores which was
1.40 for ginger and 1.42 for control that produced a difference of 0.02 between the ginger and
placebo.6 This result showed nausea was more severe in the ginger arm however, this is not
considered significant.6
Table 2: Calculation for treatment of Ansair et Al.6
Study

CER

EER

RBI

ABI

NNT

Ansari et Al.

32%

40%

25%

8%

13

Thamlikitkul et Al. double-blind study consisted of only 34 participants and the study
was conducted in Thailand. Each participant was assigned to a group by a stratified
randomization table.7 The study consisted of a ginger group (n=19) and control group (n=15).7
However, the groups were switched
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in the next cycle of chemotherapy to receive the opposite intervention. Although one participant
did not fully complete the intervention, no participants were excluded from the study.7 The
intervention of Thamlikitkul et Al. consisted of participants consuming a 500-mg ginger capsule
or placebo twice a day for five days which stated on the first day of the chemotherapy cycle.7
The participants of this study were prophylactically treated with anti-emetics and were allowed
to use rescue anti-emetics if symptoms became intolerable.7
The results of Thamlikitkul et Al. study found that the primary outcome of that study was
not a significant difference between the ginger and the control.7 The data from this study was
presented as continuous and not able to be converted to dichotomous. Thamlikitkul et Al.
collected data via VAS and presented the data as a change in mean from the baseline7. The study
used ANOVA test to determine the difference in nausea score. The results of the study are
represented in Table 3. The interpretation of the results displays a mean nausea score of 3 with a
small treatment effect of this trial.7 There showed no significance difference of acute or delayed
nausea in both arms of the study.7
Table 3: Thamlikitkul et Al. study that used ginger used as a treatment for CIN in
comparison to a placebo of the primary outcome7
Thamlikitkul et Al.

CI

P value

Ginger vs. Control rating
95%, -3 to 9
p=0.30
severity of nausea
Lua et Al. enrolled 75 participants that were diagnosed with breast cancer and receiving
chemotherapy into a single-blind study which took place in Malaysia.8 The subjects were
randomized into two groups by using a technique known as block randomization 1:1 ratio.8 The
inclusion and exclusion criteria of this study is displayed in Table 1. The placebo group consisted
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of 37 participants and the ginger intervention group consisted on 38 participants.8 The
intervention of Lua et Al. study used ginger essential oil to treat CIN. In the comparison group,
the placebo was a fragranced matched oil. Participants were instructed to wear a necklace for 5
days and breathe deeply three times a day with the oil bottle under the nose for 2-minute
duration.8 The groups interventions were crossed over to the opposite intervention on the second
round of chemotherapy. Lua et Al. collected data by providing a VAS for the participants to
record the severity of nausea within a diary. The participants were instructed to self-record
severity of nausea three times a day, 9 am, 3 pm, and 9 pm respectively.8 At the end of the study,
a total of 60 participants from each group were accounted for in the results of the study with 30
subjects in each arm.8
The results of Lua et Al. determined that the treatment of ginger essential oil showed no
significant difference on the VAS score of nausea.8 The results were presented in continuous
data in the trial and could not be converted to dichotomous. Lua et Al. reported five days of data
via ANOVA to determine the difference in severity of nausea between the two interventions.8
The results are displayed in Table 4 of this systematic review. The interpretation of the results
shows a mean difference of 1.83 between the essential oil and fragranced oil which is a small
treatment effect.8
Table 4: Ginger as an essential oil vs. a fragranced oil for the treatments of CIN
Study: Lua et Al.

F stat

P value

Ginger Essential oil vs.
F (1, 58) = 1.82
P=0.183
fragranced oil
Lua et Al. used a patient oriented questionnaire to determine the HRQoL profile of the
breast cancer participants. The questionnaire EORTC QLQ-30 analyzed five areas of functioning
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and eight symptoms associated with chemotherapy cycles.8 Specifically, nausea and vomiting
were grouped together on the HRQoL scale. The results showed a significant difference of
reduction in symptoms while participants were using the ginger essential oil intervention.8 The
results reported a p < 0.001 which is significant8.
Ginger as a treatment intervention was well tolerated across all studies. Participants in all
of the studies did not have any negative reactions to ginger.
DISCUSSION
Chemotherapy is a treatment for cancer and it can produce nausea as a side effect that can
decrease the quality of life in patients. This selective EBM systematic review analyzed whether
or not ginger is an effective treatment to reduce the severity of nausea cause by chemotherapy.
All three randomized control trials evaluated in this review showed ginger is not a significant
treatment for CIN. However, the HRQoL profile measured in the study produced by Lua et Al.
showed an increase of the quality of life in patients experiencing nausea and vomiting as a
symptom produced by chemotherapy.
Ginger has been used traditionally for centuries and it can be easily found in markets
across the globe.5 The earth-produced plant rarely causes adverse reactions unless it is consumed
in in large doses.5 The recommended dosing for nausea is ranged between 250 mg to 2 grams a
day divided over three to four times a day.5 Ginger has the potential for interaction with
medications such as anti-platelets, anticoagulants, antihypertensive, hypoglycemic agents,
nonsteroidal anti-inflammatory drugs, salicylates, and thrombolytic agents.5 However, there are
no contraindications identified for individuals using ginger.5

Taurino, Chemotherapy-induced nausea & ginger, 10
This systematic review used three randomized control trials to determine if ginger can
improve nausea as a side effect to patients receiving chemotherapy. Although each trial found
data with insignificant results, it does not exclude ginger as a treatment. This non-pharmalogical
treatment should not be excluded because there were many limitations to the studies which could
have manipulated the results. Therefore, it would be beneficial if future clinical trials used ginger
with different parameters than the studies of this systematic review.
Additionally, each study contained limitations which include population size, time
period, and recording of symptoms. Thamlikitkul et Al. study was limited by the sample size
which consisted of only 34 participants.7 In the next study conducted by Ansari et Al., the time
period of treatment only lasted for 3 days.6 It is possible that ginger needs a longer treatment
time to see a decrease in nausea severity. Finally, the study conducted by Lua et Al. allowed
patients to self-record symptoms which could have skewed the results of the study.8 It would be
more accurate with computers tracking when patients record their symptoms.
Another limiting factor, each study used in the review was conducted within another
country outside of the United States. These countries include Iran, Thailand, and Malaysia. The
standards in these countries may not be consistent with those in America which puts a limitation
of the results. Therefore, the standards of treatment within the United States could possibly
change the results if future trials are conducted here.
The final limitation includes prophylactic treatment of CIN with anti-emetic medications
to the participants in the study. Although medical practice does not inflict harm on patients that
seek treatment, the administration of anti-emetics prior to chemotherapy could have influenced
the results. In the studies conducted by Thamlikitkul et Al. and Lua et Al., the participants were
prophylactically treat with anti-emetics.7,8
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CONCLUSION
The evidence evaluated in this systematic review found that ginger is not effective at
improving the severity of nausea produced by chemotherapy. The study conducted by Lua et Al.
found that the health-related quality of life showed significant improvement of nausea and
vomiting (p < 0.001) by ginger essential oil aromatherapy via the European Organization for
Research and Treatment of Cancer Quality of Life Questionnaire.8 However, each of the control
trials did not find any significant improvement to the severity of nausea during the intervention
compared to the control group. Since there are multiple limitations to these control trials, ginger
as a treatment for CIN should not be excluded as a for a future intervention. New research trials
to investigate the potential of ginger would benefit by being conducted in America, a larger
sample size, a longer treatment interval, and a strict recording of symptoms.
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